Clinical trial
Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in…
NCT00482716 · St. Bartholomew's Hospital, Other · Unknown status
Key facts
| NCT number | NCT00482716 |
|---|---|
| Title | Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer |
| Official title | Randomized Controlled Study of Iron Supplementation to Support the Response to Recombinant Human Erythropoietin for the Treatment of Chemotherapy-Induced Anaemia |
| Lead sponsor | St. Bartholomew's Hospital, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Biological, Dietary Supplement |
| Interventions | epoetin alfa, epoetin beta, iron dextran complex, iron sucrose injection |
| Enrollment | 80 |
| Start date | Jan 1, 2007 |
| First posted | Jun 5, 2007 |
| Last update posted | Jan 10, 2014 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: